These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26355873)

  • 21. MicroRNA-mediated interactions between host and hepatitis C virus.
    Li H; Jiang JD; Peng ZG
    World J Gastroenterol; 2016 Jan; 22(4):1487-96. PubMed ID: 26819516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sustained virologic response of nonresponder hepatitis C virus patients with retreatment.
    Akhan SC; Gurel E; Sayan M
    Indian J Pathol Microbiol; 2011; 54(1):81-4. PubMed ID: 21393883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular microRNA networks regulate host dependency of hepatitis C virus infection.
    Li Q; Lowey B; Sodroski C; Krishnamurthy S; Alao H; Cha H; Chiu S; El-Diwany R; Ghany MG; Liang TJ
    Nat Commun; 2017 Nov; 8(1):1789. PubMed ID: 29176620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus.
    Todorovska B; Caloska-Ivanova V; Dimitrova-Genadieva M; Trajkovska M; Popova-Jovanovska R; Grivceva-Stardelova K; Licoska-Josifovic F; Andreevski V; Curakova-Ristovska E; Joksimovic N
    Open Access Maced J Med Sci; 2019 May; 7(10):1641-1648. PubMed ID: 31210815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of microRNAs in antiviral responses to dengue infection.
    Wong RR; Abd-Aziz N; Affendi S; Poh CL
    J Biomed Sci; 2020 Jan; 27(1):4. PubMed ID: 31898495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C Virus: Evading the Intracellular Innate Immunity.
    Ferreira AR; Ramos B; Nunes A; Ribeiro D
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32183176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Hunyady B; Kovács B; Battyáni Z
    Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
    Jacobson IM; Dore GJ; Foster GR; Fried MW; Radu M; Rafalsky VV; Moroz L; Craxi A; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Scott J; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):403-13. PubMed ID: 24907225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action.
    Paeshuyse J; Dallmeier K; Neyts J
    Curr Opin Virol; 2011 Dec; 1(6):590-8. PubMed ID: 22440916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on antiviral therapy for chronic hepatitis C.
    Toniutto P; Fabris C; Bitetto D; Fornasiere E; Rapetti R
    Discov Med; 2007 Feb; 7(37):27-32. PubMed ID: 17343802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users].
    Ruzić M; Milotka F; Klasnja B; Pobor M; Svarc D; Jovelic A; Fabri I
    Srp Arh Celok Lek; 2010; 138(1-2):43-9. PubMed ID: 20425908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon.
    Ikeda M; Kato N
    J Pharmacol Sci; 2007 Oct; 105(2):145-50. PubMed ID: 17928739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.
    Xiang Y; Tang JJ; Tao W; Cao X; Song BL; Zhong J
    J Virol; 2015 Jul; 89(13):6805-16. PubMed ID: 25903345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the hepatitis C virus genome replication by miR-199a.
    Murakami Y; Aly HH; Tajima A; Inoue I; Shimotohno K
    J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.